Is there any association between impaired health-related quality of life and non-adherence to medical therapy in inflammatory bowel disease?

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 11, 2012, Pages 1298-1303

  Horváth, Gábor ^a   Farkas, Klaudia ^b   Hollósi, Renáta ^b   Nagy, Ferenc ^b   Szepes, Zoltán ^b   Papp, Mária ^c   Palatka, Károly ^c   Miheller, Pál ^d   Lakatos, László ^e   Szamosi, Tamás ^f   Nyári, Tibor ^b   Wittmann, Tibor ^b   Molnár, Tamás ^b  

^a Semmelweis Health Centre of Miskolc   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e Csolnoky F County Hospital   (Hungary)

^f State Health Centre   (Hungary)

Author keywords

Health related quality of life; Inflammatory bowel disease; Medical adherence

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DIARRHEA; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SOCIAL STATUS; TERTIARY HEALTH CARE; TREATMENT REFUSAL; ULCERATIVE COLITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; AMINOSALICYLIC ACIDS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; CROHN DISEASE; DIARRHEA; FEMALE; HEALTH STATUS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MENTAL HEALTH; MIDDLE AGED; MOTOR ACTIVITY; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; SMOKING; SOCIAL PARTICIPATION; YOUNG ADULT;

EID: 84867506408     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.703233     Document Type: Article

References (31)

1. Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: Psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005;11:909-18. (Pubitemid 41428850)
2. Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, Schulz T, Stray N, Vatn M, Moum B. Relationship between sick leave, unemployment, disability and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006;12:402-12.
3. San Roman AL, Bermejo F, Carrera E, Pérez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease, Rev Esp Enferm Dig. 2005;97:249-57. (Pubitemid 40755660)
4. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24(Suppl 170):2-6. (Pubitemid 20015811)
5. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
6. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317:1625-9. (Pubitemid 18010466)
7. Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Sostegni R, Rocca R, Pera A, Gevers A, Mary JY, Colombel JF, Rutgeerts P. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60:505-12. (Pubitemid 39311530)
8. D'Haens G, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions caused by infusion of intestinal content in excuded ileum in Crohn's disease. Gastroenterology 1998;114:262-7. (Pubitemid 28093532)
9. Riley SA, Mani V, Goodmon MJ, Dutt S, Herd ME. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000;47:404-9.
10. Lakatos L, Czeglédi Z, Dávid G, Kispál Z, Kiss LS, Palatka K, Kristóf T, Molnár T, Salamon A, Demeter P, Miheller P, Szamosi T, Banai J, Papp M, Bene L, Kovács A, Rácz I, Lakatos PL. Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease. Orv Hetil 2010;151:250-8.
11. Robinson A. Review article: improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008;27:9-14. (Pubitemid 351328756)
12. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
13. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
14. Lakatos L, Mester G, Erdélyi Z, Balogh M, Szipócs I, Kamarás G, Lakatos PL. Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001. Orv. Hetil 2003;144:1819-27.
15. Stark R, König HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006;24:797-814. (Pubitemid 44232107)
16. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, Dobkin PL. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535-44. (Pubitemid 36875345)
17. Casellas F, Rodrigo L, Nino P, Pantiga C, Riestra S, Malagelada JR. Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years. Inflamm Bowel Dis 2007; 13:1395-400. (Pubitemid 350206852)
18. Petrak F, Hardt J, Clement T, Börner N, Egle UT, Hoffmann SO. Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol 2001;36:375-82. (Pubitemid 32250733)
19. Martin A, Leone L, Fries W, Naccarato R. Quality of life in inflammatory bowel disease. Ital J Gastroenterol 1995;27: 450-4. (Pubitemid 26006762)
20. Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, Henriksen M, Stray N, Kjellevold O, Vatn M, Moum B; IBSEN Study Group. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004;4:365-73. (Pubitemid 38526725)
21. Casellas F, Arenas JI, Baudet JS, Fábregas S, García N, Gelabert J, Medina C, Ochotorena I, Papo M, Rodrigo L, Malagelada JR. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005;11:488-96. (Pubitemid 40704084)
22. Romberg-Camps MJ, Bol Y, Dagnelie PC, Kester AD, Engels LG, van Deursen C, Hameeteman WH, Pierik M, Wolters F, Russel MG, Stockbrügger RW. Fatigue and health-related quality oflife in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010;16:2137-47.
23. Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. BMC Gastroenterol 2001;2:1.
24. Bastida G, Nos P, Aguas M, Iborra M, Ortiz V, Garrigues V, Estevan R, Ponce J. The effects of thiopurine therapy on health related quality of life in Inflammatory Bowel Disease patients. BMC Gastroenterol 2010;10:26.
25. Kane SV, Cohen R, Aikens J, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001;96:2929-33. (Pubitemid 32959535)
26. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, Dobkin PL. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535-44. (Pubitemid 36875345)
27. Russel MG, Nieman FH, Bergers JM, Stockbrügger RW. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group. Eur J Gastroenterol Hepatol 1996;8:1075-81. (Pubitemid 26383865)
28. Horne R, Parham R, Driscoll R, Robinson A. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:837-44.
29. Rawsthrone P, Clara I, Graff LA, Bernstein KI, Carr R, Walker JR, Ediger J, Rogala L, Miller N, Bernstein CN. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products. Gut 2012;61:521-7.
30. Stjernman H, Tysk C, Almer S, Ström M, Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scand JGastroenterol 2010;45:696-706.
31. Hommel KA, Davis CM, Baldassano RN. Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol 2008;33:867-74.